Analysts Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) Target Price at $16.88
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the nine analysts that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price […]
More Stories
ARK 21Shares Active On-Chain Bitcoin Strategy ETF (NYSEARCA:ARKC) Announces $3.18 Dividend
ARK 21Shares Active On-Chain Bitcoin Strategy ETF (NYSEARCA:ARKC – Get Free Report) declared a dividend on Friday, December 27th,NASDAQ Dividends...
Polar Power, Inc. (NASDAQ:POLA) Short Interest Update
Polar Power, Inc. (NASDAQ:POLA – Get Free Report) was the recipient of a large decrease in short interest during the...
Short Interest in iShares MSCI EAFE Small-Cap ETF (NASDAQ:SCZ) Decreases By 24.8%
iShares MSCI EAFE Small-Cap ETF (NASDAQ:SCZ – Get Free Report) was the recipient of a large drop in short interest...
Brandes International ETF (BATS:BINV) Announces $0.16 Dividend
Brandes International ETF (BATS:BINV – Get Free Report) declared a dividend on Friday, December 27th,NASDAQ Dividends reports. Investors of record...
BondBloxx JP Morgan USD Emerging Markets 1-10 Year Bond ETF (BATS:XEMD) Declares Dividend Increase – $0.23 Per Share
BondBloxx JP Morgan USD Emerging Markets 1-10 Year Bond ETF (BATS:XEMD – Get Free Report) declared a dividend on Friday,...
Aptus Collared Investment Opportunity ETF (BATS:ACIO) Announces Dividend of $0.03
Aptus Collared Investment Opportunity ETF (BATS:ACIO – Get Free Report) declared a dividend on Friday, December 27th,NASDAQ Dividends reports. Investors...